8 ugers intervaller under behandling med lapatinib for at sikre, det ikke faldt til under institutionens nedre normalgrænse.
In clinical trials LVEF was monitored at approximately eight week intervals during treatment with lapatinib to ensure it did not decline to below the institutions lower limit of normal.